Shares of Humana Inc. (NYSE:HUM – Get Free Report) have received a consensus recommendation of “Hold” from the thirty brokerages that are currently covering the company, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, fifteen have assigned a hold recommendation and fourteen have issued a buy recommendation on the company. The average 1 year price objective among brokerages that have issued ratings on the stock in the last year is $403.9130.
Several analysts have issued reports on the company. Wells Fargo & Company upgraded Humana from an “equal weight” rating to an “overweight” rating and upped their target price for the company from $227.00 to $502.00 in a report on Monday, July 13th. Bank of America raised shares of Humana from a “neutral” rating to a “buy” rating and set a $500.00 price target on the stock in a research report on Wednesday, July 29th. Lake Street Capital began coverage on shares of Humana in a report on Thursday, July 30th. They issued a “buy” rating for the company. HSBC cut shares of Humana to a “hold” rating in a research report on Thursday, July 30th. Finally, Robert W. Baird set a $390.00 target price on shares of Humana in a research note on Thursday, July 30th.
Read Our Latest Stock Analysis on HUM
Institutional Trading of Humana
Humana Price Performance
HUM stock opened at $392.72 on Friday. The company has a debt-to-equity ratio of 0.62, a current ratio of 1.74 and a quick ratio of 1.74. The business has a 50 day simple moving average of $385.08 and a 200-day simple moving average of $287.78. The firm has a market capitalization of $47.16 billion, a PE ratio of 37.15, a price-to-earnings-growth ratio of 2.23 and a beta of 0.72. Humana has a 1 year low of $163.11 and a 1 year high of $428.88.
Humana (NYSE:HUM – Get Free Report) last posted its quarterly earnings results on Wednesday, July 29th. The insurance provider reported $7.61 EPS for the quarter, beating the consensus estimate of $7.27 by $0.34. Humana had a return on equity of 11.20% and a net margin of 0.88%.The firm had revenue of $40.89 billion during the quarter, compared to analysts’ expectations of $40.58 billion. During the same quarter last year, the firm earned $6.27 earnings per share. The business’s revenue for the quarter was up 26.2% on a year-over-year basis. Equities research analysts anticipate that Humana will post 9.12 earnings per share for the current fiscal year.
Humana Company Profile
Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.
In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.
Further Reading
- Five stocks we like better than Humana
- Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes Shape
- SEC Probe Puts Wall Street Leverage Risk Back in Focus
- A Bearish-Dollar Options Surge Raises the Stakes for Warsh at Jackson Hole
- Five Below’s Turnaround Is Working—But Has the Stock Run Too Far?
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.
